Zephyr Sciences, Inc.

Represented Zephyr Sciences, Inc. in negotiation of an exclusive worldwide licensing agreement with Xoma Ltd. (Nasdaq: XOMA) for the research, development and commercialization of products related to Xoma’s bactericidal/permeability-increasing protein (BPI), including its NEUPREX® product.